BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6748579)

  • 1. [Characteristics of iron metabolism in patients with chronic hepatitis].
    Dorofeev GI; Tel'nykh IuV
    Klin Med (Mosk); 1984 May; 62(5):64-6. PubMed ID: 6748579
    [No Abstract]   [Full Text] [Related]  

  • 2. [Various characteristics of collagen metabolism in patients with chronic diseases of the liver].
    Geĭvandova NI; Iagoda AV; Mosin VI
    Klin Med (Mosk); 1989 Nov; 67(11):59-62. PubMed ID: 2625962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron.
    Hayashi H; Takikawa T; Nishimura N; Yano M; Isomura T; Sakamoto N
    Am J Gastroenterol; 1994 Jul; 89(7):986-8. PubMed ID: 8017395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Variations in the metabolism of iron in chronic liver diseases].
    Povés E; Moreno Otero R; Estrada A; Del Pozo A; Ruiz Ayuso F; Cantero J; Pajares JM
    Rev Esp Enferm Apar Dig; 1988 Jan; 73(1):17-21. PubMed ID: 3363200
    [No Abstract]   [Full Text] [Related]  

  • 5. [Aspects of iron metabolism in acute hepatitis].
    Betetto D; Cristina P; Cappelletti S
    Arch Patol Clin Med; 1965 Dec; 42(2):139-53. PubMed ID: 5860704
    [No Abstract]   [Full Text] [Related]  

  • 6. [Iron metabolism and enteral iron absorption in liver diseases].
    Rommel K; Gladtke E; Mähr G; Grimmel K; Burkhardt H
    Schweiz Med Wochenschr; 1968 Nov; 98(47):1854-9. PubMed ID: 5704710
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation.
    Farinati F; Cardin R; D'Errico A; De Maria N; Naccarato R; Cecchetto A; Grigioni W
    Hepatology; 1996 Jun; 23(6):1468-75. PubMed ID: 8675166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of chronic hepatitis C to interferon-alpha treatment and relationship with iron metabolism.
    Martín-Vivaldi R; Nogueras F; González A; Quintero D; Pinel LM; Castro T; Hernández A
    Rev Esp Enferm Dig; 1997 Jul; 89(7):523-30. PubMed ID: 9265838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of iron metabolism in cases of hepatitis and liver cirrhosis.
    Stojcevski T; Grunevska B; Davcev P; Marković V
    Acta Med Iugosl; 1970; 24(1):41-8. PubMed ID: 5455213
    [No Abstract]   [Full Text] [Related]  

  • 10. [Liver hemosiderosis in chronic hepatitis].
    Smirnov OA; Anichkov NM; Radchenko VG
    Arkh Patol; 2003; 65(1):39-42. PubMed ID: 12669612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State of the iron metabolism in patients with chronic hepatitis C type C does not influence antiviral treatment with interferon and ribavirin.
    Jurczyk K; Karpińska E; Wawrzynowicz-Syczewska M; Morańska I; Noceń I; Chlubek D; Boroń-Kaczmarska A
    Hepatogastroenterology; 2008; 55(82-83):557-61. PubMed ID: 18613407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron overload and response to alpha-interferon in chronic hepatitis C.
    Girelli CM; Mirata C; Lesinigo E; Casiraghi A
    Am J Gastroenterol; 1995 Jan; 90(1):170-1. PubMed ID: 7695721
    [No Abstract]   [Full Text] [Related]  

  • 13. Magnetic resonance imaging and different levels of iron overload in chronic liver disease.
    Rocchi E; Cassanelli M; Borghi A; Paolillo F; Pradelli M; Casalgrandi G; Burani A; Gallo E
    Hepatology; 1993 Jun; 17(6):997-1002. PubMed ID: 8514272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
    D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
    Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic hepatitis B, hemosiderosis, and hepatic fibrosis in a renal graft recipient].
    Zubkin ML; Pavlov ChS; Chervinko VI; Semenenko TA; Balakirev EM; Zolotarevskiĭ VB; Frolov AV; Baranova FS; Repetiĭ NG; Bakulin IG; Stanke AA; Novozhenov VG
    Klin Med (Mosk); 2009; 87(6):64-7. PubMed ID: 19670722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Abnormal iron metabolism in the special type of hepatocerebral encephalopathy. I. Clinical and pathological findings of four cases of special type of hepatocerebral encephalopathy with hemochromatosis].
    Saito A
    Seishin Shinkeigaku Zasshi; 1984; 86(3):153-66. PubMed ID: 6484049
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of iron metabolism in children with chronic hepatitis B -- prognostic factor in interferon alpha therapy.
    Chrobot A; Chrobot AM; Szaflarska-Szczepanik A
    Med Sci Monit; 2002 Apr; 8(4):CR269-73. PubMed ID: 11951069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal aminopyrine metabolism in patients with chronic hepatitis.
    Hepner GW; Piken E; Lechago J
    West J Med; 1981 May; 134(5):390-3. PubMed ID: 7257348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver hepcidin mRNA correlates with iron stores, but not inflammation, in patients with chronic hepatitis C.
    Aoki CA; Rossaro L; Ramsamooj R; Brandhagen D; Burritt MF; Bowlus CL
    J Clin Gastroenterol; 2005 Jan; 39(1):71-4. PubMed ID: 15599216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical improvement of chronic hepatitis C after gastrointestinal bleeding.
    Kato S; Arao M; Kuriki J; Tagaya T; Takiya S; Kato K; Takikawa T; Hayashi H
    Nagoya J Med Sci; 1994 Dec; 57(3-4):153-7. PubMed ID: 7898571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.